Company news
Nippon Chemiphar Co., Ltd. (TSE:4539) news
Nippon Chemiphar Co., Ltd. news releases on 6ix. Latest, Jan 15, 2026: Nippon Chemiphar : Patient Enrollment Started for Phase IIa Clinical Trial on δ-Opioid…
Press releases & updates
Nippon Chemiphar : Patient Enrollment Started for Phase IIa Clinical Trial on δ-Opioid Receptor Agonist NC-2800 in Patients with Depression.
January 15, 2026
Nippon Chemiphar : Notice Concerning Recording of Gain on Sales of Investment Securities (Extraordinary Income)
June 4, 2025
Nippon Chemiphar : Notice of the 93rd Ordinary General Meeting of Shareholders.
May 26, 2025
Nippon Chemiphar : Notice of the 91st Ordinary General Meeting of Shareholders.
May 29, 2023